LYMPHOCYTE TYPING, NEGATIVE CONTROL— 510(k) K761008
Substantially EquivalentHyland Therapeutic Div., Travenol Laboratories
FDA 510(k) clearance K761008 for LYMPHOCYTE TYPING, NEGATIVE CONTROL, Substantially Equivalent on 1977-04-06. Applicant: Hyland Therapeutic Div., Travenol Laboratories.
Clearance details
- Applicant
- Hyland Therapeutic Div., Travenol Laboratories
- Product code
- Code LGO
- Advisory panel
- Hematology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Mchenry, IL, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.